Gender Trends in Psychotropic Medication Use in Autism

被引:1
作者
Huber, Christopher R. [1 ]
Fanaro, Zachary [2 ]
Soti, Varun [3 ]
机构
[1] Lake Erie Coll Osteopath Med, Med Sch, Elmira, NY USA
[2] Lake Erie Coll Osteopath Med, Anat & Neuroanat, Elmira, NY USA
[3] Lake Erie Coll Osteopath Med, Pharmacol & Therapeut, Elmira, NY 14901 USA
关键词
prescription medication; systematic literature review; sex differences; psychotropic drugs; autism spectrum disorders; SPECTRUM DISORDER ASD; PRESCRIPTION TRENDS; CHILDREN; ADOLESCENTS; HEALTH; SERVICE; COMORBIDITIES; PREVALENCE; PEOPLE; DRUGS;
D O I
10.7759/cureus.26447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autism is a neurodevelopmental condition that includes differences in social communication and restrictive, repetitive behavior. Its diagnosis is far more common in men than women. Therefore, a female phenotype of autism might not concern caregivers or be detected early by clinical assessments. Given that medications address problematic behaviors rather than autism, different problems associated with autism necessitate other treatments. We reviewed existing literature on gender differences in psychotropic drug usage in autism patients and found that antidepressants, anticonvulsants, and mood stabilizers were more common in females, while stimulants and antipsychotics were predominant in males. This review highlights that autistic men and women receive different pharmacologic agents, likely attributable to gender-specific trends in presenting problematic behaviors.
引用
收藏
页数:13
相关论文
共 37 条
[1]   Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK [J].
Alfageh, Basmah H. ;
Man, Kenneth K. C. ;
Besag, Frank M. C. ;
Alhawassi, Tariq M. ;
Wong, Ian C. K. ;
Brauer, Ruth .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2020, 50 (02) :625-633
[2]  
APA, 1980, Diagnostic and statistical manual of mental disorders
[3]  
Attwood T., 2007, The complete guide to Asperger's syndrome
[4]   Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany [J].
Bachmann, Christian J. ;
Manthey, Thomas ;
Kamp-Becker, Inge ;
Glaeske, Gerd ;
Hoffmann, Falk .
RESEARCH IN DEVELOPMENTAL DISABILITIES, 2013, 34 (09) :2551-2563
[5]  
Butler Merlin G, 2018, J Ment Health Clin Psychol, V2, P17
[6]   Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders [J].
Coury, Daniel L. ;
Anagnostou, Evdokia ;
Manning-Courtney, Patricia ;
Reynolds, Ann ;
Cole, Lynn ;
Mccoy, Robin ;
Whitaker, Agnes ;
Perrin, James M. .
PEDIATRICS, 2012, 130 :S69-S76
[7]   Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study [J].
Croteau, Caroline ;
Mottron, Laurent ;
Dorais, Marc ;
Tarride, Jean-Eric ;
Perreault, Sylvie .
AUTISM, 2019, 23 (08) :2020-2030
[8]  
Croteau C, 2017, J POPUL THER CLIN PH, V24, pE19, DOI 10.22374/1710-6222.24.3.2
[9]   Gender and Injuries Predict Stimulant Medication Use [J].
Dalsgaard, Soren ;
Leckman, James F. ;
Nielsen, Helena Skyt ;
Simonsen, Marianne .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (05) :253-259
[10]  
Doyle Carolyn A, 2012, Dialogues Clin Neurosci, V14, P263